Movers

Bitcoin, Ethereum Slip While Dogecoin Surges Ahead Of Presidential Election; Analyst Predicts BTC Will Hit $100K+ Regardless Of Trump Or Harris Win

Bitcoin plummeted further, but Dogecoin rose as cryptocurrency investors braced for the high-stakes presidential election.

'Messi Of AI': Wall Street Analyst Gushes Over 'Robust' Earnings From Palantir

Wedbush analyst Dan Ives is out with an early reaction to Palantir's "eye-popping" results, featuring beats across the board.

Fertilizer Stocks Traded Higher On Monday: Here's Why

Fertilizer stocks, including Mosaic Company (NYSE: MOS) and Nutrien Ltd (NYSE: NTR), got a lift on Monday after Belarusian President Alexander Lukashenko suggested a coordinated production cut in potash with Russian producers.

Lattice Semiconductor Shares Fall After Q3 EPS Meet Estimate; Revenues Miss: Details

Lattice Semiconductor reported its third-quarter results after Monday's closing bell. Here's a look at the details from the report:

NXP Semiconductors Shares Dip After Q3 Results: EPS Beat, Revenues In-Line, Q4 Guidance Below Estimates

NXP Semiconductors reported its third-quarter results after Monday's closing bell. Here's a look at the key figures from the quarter.

Cleveland-Cliffs Q3 Earnings: Revenue, EPS Miss On 'Weaker Demand And Pricing,' Shares Slide

Cleveland-Cliffs reports financial results for the third quarter after the bell on Monday.

Palantir Q3 Earnings: Revenue Beat, EPS Beat, Customers Up 39%, Guidance Raise — Results Driven By 'Unrelenting AI Demand That Won't Slow Down'

Palantir reported third-quarter revenue of $725.52 million, beating the consensus estimate of $701.13 million, according to Benzinga Pro.

Hims & Hers Health Reports Better-Than-Expected Q3 Results: Details

Hims & Hers Health reported its third-quarter results after Monday's closing bell. Here's a look at the details from the report.

Globalstar Stock Is Surging Monday: What's Going On?

Globalstar Inc. (AMEX: GSAT) shares are trading higher Monday after the company on Friday announced an extended services agreement with Apple Inc. (NASDAQ: AAPL), which includes plans to build and launch a new mobile satellite services (MSS) network.

B. Riley Shares Are Moving Lower Monday: What's Going On?

B. Riley Financial (NASDAQ: RILY) shares are trading lower Monday after the company announced it expects to record a combined impairment of approximately $120 million due to its investments in Franchise Group.

Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo

JMP Securities initiates coverage on Summit Therapeutics, citing promising data for ivonescimab in NSCLC and setting a $32 price target amid strong trial results.

What's Going On With BCE Shares Monday?

BCE stock is moving lower on Monday after the company's subsidiary, Bell Canada, entered into a definitive acquisition agreement to acquire Ziply Fiber.

What's Going On With New York Times Stock Monday?

New York Times (NYSE:NYT) shares are moving lower on Monday. The company reported third-quarter financial results before the open. In addition, hundreds of employees represented by the Times Tech Guild have reportedly gone on strike.

What's Going On With NLS Pharmaceutics Shares Monday?

NLS Pharmaceutics shares are moving higher on Monday after the company announced it entered into a definitive merger agreement with Kadimastem.

Nuclear Stocks Are Tumbling Monday: What's Going On?

Nuclear stocks are trading lower across the board on Monday after regulators rejected Talen Energy Corp's (NASDAQ:TLN) plans to increase power for an Amazon.com Inc (NASDAQ:AMZN) data center.

Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential

Piper Sandler initiates coverage of Nektar Therapeutics, citing REZPEG's Treg-focused action as a potential breakthrough for Alopecia areata treatment.

Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug

Ascendis Pharma and Novo Nordisk sign exclusive global license for TransCon technology, aiming to advance obesity, type 2 diabetes, and cardiovascular treatments.

Why Is Integra LifeSciences Stock Soaring On Monday?

Integra LifeSciences' Q3 results show adjusted EPS of $0.41 and revenue at $380.83 million. Codman segment grows 1%, while Tissue Tech sees a 3.6% decline.

Zoetis Q3 Earnings Beat, Companion Animal Segment Growth Gives Confidence Into 2025: Analyst

Zoetis Inc's Q3 2024 results show a 16% EPS increase and an 11% revenue boost. The company raises its 2024 guidance, highlighting strong global growth in key segments.

What's Going On With Palantir Stock Monday?

Palantir Technologies Inc (NYSE:PLTR) shares are in the spotlight Monday ahead of earnings after the bell. Here's what you need to know before the report.

Integra LifeSciences Posts Upbeat Results, Joins Air Transport Services, Freshpet, Yum China And Other Big Stocks Moving Higher On Monday

Alibaba Layoffs Hit Metaverse Division: Will The Chinese E-Commerce Giant Double-Down On AI?

Alibaba Group Holding Limited (NYSE:BABA) the Chinese e-commerce giant, has recently made significant cuts to its metaverse division, Yuanjing, as part of a broader trend of tech companies scaling back their investments in the once-hyped sector.

Stonepeak Lands ATSG In $3.1 Billion Deal, Offering 29% Premium: Details

ATSG to be acquired by Stonepeak for $3.1 billion, representing a 29.3% premium over last closing. ATSG will become a private entity.

12 Health Care Stocks Moving In Monday's Intraday Session

12 Industrials Stocks Moving In Monday's Intraday Session

Constellation Energy Q3: Earnings Beat, Revised FY24 EPS Guidance & More

Constellation Energy reported Q3 results, revised EPS guidance below estimates. Sales & EPS beat expectations, driven by nuclear & market conditions.

This Peloton Interactive Analyst Gives A Double Upgrade, Raises Forecast By More Than 100%

Peloton smashed sales estimates in Q1. One analyst says the company has the potential for $300-million EBITDA this year.

What's Going On With Hims & Hers Health Stock Monday?

Hims & Hers Health will report third-quarter financial results after the market close on Monday. Analysts expect the company to report earnings of 4 cents per share and revenue of $382.2 million, according to estimates from Benzinga Pro.

Exxon Mobil Q3 Earnings Impress Analysts With Record Production, Dividend Hike

Exxon Mobil reported upbeat Q3 earnings, driven by record production. Analysts maintain Hold/Sector Perform ratings on macro concerns.

What's Going On With Entegris Shares Monday?

Entegris shares are moving lower on Monday after the company reported worse-than-expected 2024 third-quarter financial results before the market opened.